SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



        Date of Report (Date of earliest event reported): March 31, 2004
                                                          --------------



                        Blonder Tongue Laboratories, Inc.
             ------------------------------------------------------
             (Exact Name of registrant as specified in its charter)



       Delaware                          1-14120                  52-1611421
-------------------------------    ------------------------    ----------------
(State or other jurisdiction of    (Commission File Number)    (I.R.S. Employer
      incorporation)                                         Identification No.)



                One Jake Brown Road, Old Bridge, New Jersey 08857
               ---------------------------------------------------
               (Address of principal executive offices) (Zip Code)


       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)


Item 7.  Financial Statements and Exhibits
          ---------------------------------

     (a)  Not applicable


     (b)  Not applicable


     (c)  The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated March 31, 2004.


Item 12.  Results of Operations and Financial Condition
          ---------------------------------------------

     On March 31,  2004,  the  Company  issued a press  release  announcing  its
financial  results for the fourth  quarter and year ended  December  31, 2003. A
copy of the press  release is  attached  to this  Report as Exhibit  99.1 and is
incorporated herein by reference.

                                       2


                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                        BLONDER TONGUE LABORATORIES, INC.



                                        By: /s/ Eric Skolnik
                                           -------------------------------------
                                           Eric Skolnik
                                           Senior Vice President and Chief
                                                Financial Officer

Date: March 31, 2004



                                       3